GREENWICH, Conn.--(BUSINESS WIRE)--March 20, 2006--- Needleman to Lead Efforts to Increase Active Pharmaceutical Ingredient Capabilities Through Strategic Acquisitions and Additional Internal Investments -- Aptuit, Inc. announced today that Stuart E. Needleman has been appointed Senior Director, Active Pharmaceutical Ingredient Development. Mr. Needleman brings to Aptuit over 20 years experience in the global development, scale-up, and manufacture of regulated active pharmaceutical ingredients (API) for new and established compounds. He has been involved in projects for both small and large pharmaceutical companies, successfully matching API supply from discovery to post-launch commercial quantities. Mr. Needleman will lead Aptuit's charge to bring capabilities in API development to its customers.
